Cargando…

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure

BACKGROUND: Long-term β-adrenergic receptor (β-AR) blockade reduces mortality in patients with heart failure. Chronic sympathetic hyperactivity in heart failure causes sustained β-AR activation, and this can deplete Ca(2+) in endoplasmic reticulum (ER) leading to ER stress and subsequent apoptosis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Li, Zhou, Changqing, Duan, Quanlu, Lv, Jiagao, Fu, Xiangning, Xia, Yong, Wang, Dao Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206949/ https://www.ncbi.nlm.nih.gov/pubmed/22073308 http://dx.doi.org/10.1371/journal.pone.0027294

Ejemplares similares

MicroRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo
por: Duan, Quanlu, et al.
Publicado: (2015)

Short-term effects of β2-AR blocker ICI 118,551 on sarcoplasmic reticulum SERCA2a and cardiac function of rats with heart failure
por: Gong, Haibin, et al.
Publicado: (2016)

Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor‐A expression and angiogenesis during cardiac hypertrophy in vivo
por: Duan, Quanlu, et al.
Publicado: (2016)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

MicroRNA‐214 Is Upregulated in Heart Failure Patients and Suppresses XBP1‐Mediated Endothelial Cells Angiogenesis
por: Duan, Quanlu, et al.
Publicado: (2015)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
por: Donelson, Jimmonique, et al.
Publicado: (2019)

ER Stress Negatively Modulates the Expression of the miR-199a/214 Cluster to Regulates Tumor Survival and Progression in Human Hepatocellular Cancer
por: Duan, Quanlu, et al.
Publicado: (2012)

E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca(2+)-calcineurin signaling
por: Tsai, Cheng-Yen, et al.
Publicado: (2017)

A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure
por: Koracevic, Goran, et al.
Publicado: (2022)

Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
por: Campos, Luciana Aparecida, et al.
Publicado: (2012)

Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure
por: Nagai-Okatani, Chiaki, et al.
Publicado: (2016)

Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure
por: Prado, Fernanda P., et al.
Publicado: (2017)

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure
por: Huang, Jin, et al.
Publicado: (2018)

Suppression of calcium-sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy
por: LIU, LEI, et al.
Publicado: (2016)

The effects and possible mechanism of β(2)AR gene expression in cardiocytes of canines with heart failure
por: Gong, Haibin, et al.
Publicado: (2017)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure
por: Funayama, Akira, et al.
Publicado: (2013)

A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure
por: Santolini, Marc, et al.
Publicado: (2018)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

Role and mechanism of cardiac insulin resistance in occurrence of heart failure caused by myocardial hypertrophy
por: Zheng, Liling, et al.
Publicado: (2019)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression
por: Tang, Xinmiao, et al.
Publicado: (2022)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Identification of TGF-β-related genes in cardiac hypertrophy and heart failure based on single cell RNA sequencing
por: Huang, Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oac19vqcef7nhjj9o33kn3t5ke